Literature DB >> 17726571

Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition.

R O Domínguez1, E R Marschoff, E M Guareschi, M G Repetto, A L Famulari, M A Pagano, J A Serra.   

Abstract

Increased concentrations of insulin, glucose and glycohemoglobin are associated with Type II diabetes mellitus (DM) and recognized as characteristic markers of the disease; in Alzheimer's (AD), Vascular dementia (VaD), and both dementia's with superimposed diabetes (AD + DM, VaD + DM) the knowledge is scarce. The sample (n = 122; males = 60; mean age = 73 +/- 7) comprised DM, AD, VaD, AD + DM, and VaD + DM patients, and healthy controls (C). The ANOVA's yielded significant differences between groups: Insulin p = 3.7 x 10(-3); Glucose p < 10(-12); Glycohemoglobin p = 9.2x10(-4). Comparisons between groups (DM vs. C, AD + DM vs. AD, VaD + DM vs. VaD, and demented DM vs. non-demented DM) resulted significant for all variables (Bonferroni's statistic, alpha = 0.05). Diabetic and diabetic demented patients presented significant increases largely different from controls (0.01 < p < 0.001), unlike the non-significant changes in their non-diabetic counterparts; linear relationships were found across all groups. The correlation's insulin/glucose and insulin/glycohemoglobin change to positive within demented groups, indicating a different performance of insulin in demented and non-demented subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726571     DOI: 10.1007/s00702-007-0804-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  25 in total

1.  Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.

Authors:  Valeriya Lyssenko; Peter Almgren; Dragi Anevski; Roland Perfekt; Kaj Lahti; Michael Nissén; Bo Isomaa; Björn Forsen; Nils Homström; Carola Saloranta; Marja-Riitta Taskinen; Leif Groop; Tiinamaija Tuomi
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

2.  Screening for diabetes in Indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease.

Authors:  K G Rowley; M Daniel; K O'Dea
Journal:  Diabet Med       Date:  2005-07       Impact factor: 4.359

3.  Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: the paradoxical effect of the superimposed type II diabetes mellitus condition.

Authors:  Raúl O Domínguez; Enrique R Marschoff; Eduardo M Guareschi; Arturo L Famulari; Miguel A Pagano; Jorge A Serra
Journal:  Clin Chim Acta       Date:  2005-09       Impact factor: 3.786

4.  Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease.

Authors:  B Widner; F Leblhuber; B Frick; A Laich; E Artner-Dworzak; D Fuchs
Journal:  J Neural Transm (Vienna)       Date:  2002-12       Impact factor: 3.575

Review 5.  Hyperhomocysteinemia, pteridines and oxidative stress.

Authors:  B Widner; C Enzinger; A Laich; B Wirleitner; D Fuchs
Journal:  Curr Drug Metab       Date:  2002-04       Impact factor: 3.731

6.  Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?

Authors:  D Fuchs; M Jaeger; B Widner; B Wirleitner; E Artner-Dworzak; F Leblhuber
Journal:  Clin Chem Lab Med       Date:  2001-08       Impact factor: 3.694

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  Oxidative stress in Alzheimer's and vascular dementias: masking of the antioxidant profiles by a concomitant Type II diabetes mellitus condition.

Authors:  Jorge A Serra; Enrique R Marschoff; Raúl O Domínguez; Eduardo M Guareschi; Arturo L Famulari; Miguel A Pagano; Eugenia S de Lustig
Journal:  J Neurol Sci       Date:  2004-03-15       Impact factor: 3.181

9.  Heterogeneity of non-insulin-dependent diabetes expressed as variability in insulin sensitivity, beta-cell function and cardiovascular risk profile.

Authors:  K I Birkeland; B Kilhovd; P Thorsby; P A Torjesen; R Ganss; S Vaaler; K F Hanssen
Journal:  Diabet Med       Date:  2003-01       Impact factor: 4.359

Review 10.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

View more
  3 in total

1.  Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.

Authors:  Michael Gold; Claire Alderton; Marina Zvartau-Hind; Sally Egginton; Ann M Saunders; Michael Irizarry; Suzanne Craft; Gary Landreth; Ulla Linnamägi; Sharon Sawchak
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-21       Impact factor: 2.959

2.  Determination of anti-inflammatory activities of standardised preparations of plant- and mushroom-based foods.

Authors:  Dhanushka Gunawardena; Kirubakaran Shanmugam; Mitchell Low; Louise Bennett; Suresh Govindaraghavan; Richard Head; Lezanne Ooi; Gerald Münch
Journal:  Eur J Nutr       Date:  2013-05-08       Impact factor: 5.614

3.  Systemic oxidative stress associated with the neurological diseases of aging.

Authors:  Jorge A Serra; Raúl O Domínguez; Enrique R Marschoff; Eduardo M Guareschi; Arturo L Famulari; Alberto Boveris
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.